Edition:
United Kingdom

ALK-Abello A/S (ALKb.CO)

ALKb.CO on Copenhagen Stock Exchange

1,074.00DKK
23 Apr 2019
Change (% chg)

-- (--)
Prev Close
kr.1,074.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,108
52-wk High
kr.1,230.00
52-wk Low
kr.738.00

Summary

Name Age Since Current Position

Steen Riisgaard

67 2012 Independent Chairman of the Board

Carsten Hellmann

54 2017 President, Chief Executive Officer

Lene Skole-Soerensen

59 2015 Vice Chairman of the Board

Soeren Jelert

47 2018 Chief Financial Officer, Executive Vice President

Soeren Niegel

48 Executive Vice President, Commercial Operations

Henrik Jacobi

54 Executive Vice President, Research & Development

Katja Barnkob

50 2011 Director, Employee Representative

Lars Holmqvist

60 2015 Director

Jacob Kastrup

58 2011 Director, Employee Representative

Jakob Riis

52 2013 Director

Andreas Slyngborg Holst

66 2015 Director, Employee Representative

Vincent Warnery

51 2019 Director

Gonzalo De Miquel

52 2018 Independent Director

Per Plotnikof

Vice President Corporate Communications, Investor Relations and Strategic Planning

Biographies

Name Description

Steen Riisgaard

Mr. Steen Riisgaard has been Independent Chairman of the Board of Directors at Alk-Abello A/S since March 27, 2012. He also serves as Chairman of the Company’s Remuneration and Nomination Committees and Member of the Audit and Scientific Committees. He joined the Board as Independent Member in 2011. He has experience in management and board work as well as experience in research and development and sales and marketing in international companies. He is Chairman of the Boards of Directors of COWI Holding A/S, Xellia Pharmaceutical A/S. He is also Vice Chairman of Novo A/S and The Villum Foundation, as well as Member of the Boards of The Novo Nordisk Foundation, VKR Holding A/S, Corbion N.V. and Aarhus University.

Carsten Hellmann

Mr. Carsten Hellmann has been appointed President and Chief Executive Officer at Alk-Abello A/S, effective as of January 1, 2017. He has previously been CEO of Merial and Executive Vice President and member of the Executive Committee of Sanofi. Before joining Sanofi, Carsten Hellmann held executive positions in global health care and biopharmaceutical companies including Chr. Hansen and Nunc Group. He is Board Member at Coloplast A/S.

Lene Skole-Soerensen

Ms. Lene Skole-Soerensen has been Vice Chairman of the Board of Directors of Alk-Abello A/S since March 12, 2015. She is Member of the Audit, Scientific and Nomination Committee. She has been Member of the Board since March 12, 2014. She is Chief Executive Officer of The Lundbeck Foundation and holds directorships at two subsidiaries. She has experience, financial and economic knowledge and skills in strategy and communication in international companies. She is Vice Chairman of the Board of Oersted A/S, Falck A/S and H. Lundbeck A/S as well as Member of the Board of Tryg Forsikring A/S and Tryg A/S.

Soeren Jelert

Mr. Soeren Jelert has been appointed Chief Financial Officer, Executive Vice President at ALK-ABELLO A/S, effective as of January 1, 2018. From 2008 until 2016, he was CFO at NNE, an engineering company that specializes in supporting pharmaceutical company engineering projects. Since 2016, he has been General Manager of NNE's US organization. His career has also included various finance roles at Novo Nordisk and Maersk.

Soeren Niegel

Mr. Soeren Daniel Niegel serves as Executive Vice President, Commercial Operations at Alk-Abello A/S. He joined the Company on August 1, 2012.

Henrik Jacobi

Katja Barnkob

Ms. Katja Barnkob has been Employee Representative on the Board of Directors at Alk-Abello A/S since 2011. She serves as Senior CMC Project Manager at the Company.

Lars Holmqvist

Mr. Lars Holmqvist has been Director of ALK-Abello A/S since March 12, 2015. He was previously Independent Member of the Board of Directors of ALK-Abello A/S from 2010 until March 12, 2013. He is also Member of the Company’s Remuneration Committee. Previously, he was Independent Vice Chairman of the Board of the Company between April 1, 2011 and March 27, 2012. Mr. Holmqvist is Member of the Board of BPL Holdings, UK; H. Lundbeck A/S; Tecan AG, Switzerland; Vitrolife AB and The Lundbeck Foundation. He has experience in management, finance, sales and marketing in international life science companies, including med-tech and pharmaceutical companies.

Jacob Kastrup

Mr. Jacob Kastrup has been Employee Representative on the Board of Directors of Alk-Abello A/S since 2011. He serves as Facility Manager at the Company.

Jakob Riis

Mr. Jakob Riis has served as Member of the Board of Directors of Alk-Abello A/S since March 12, 2013. He also serves as President and CEO of Falck A/S. He is Chairman of the Audit Committee at the Company. He has experience in management, sales and marketing in the international pharmaceutical industry. He is Chairman of Copenhagen Institute of Interaction Design and Board Member of Copenhagen Capacity and Falck Health Care Holding A/S.

Andreas Slyngborg Holst

Mr. Andreas Slyngborg Holst has been Director, Employee Representative at Alk-Abello A/S since 2015. He is Director, EU QPPV, Head of QPPV Office, Global Pharmacovigilance at the Company.

Vincent Warnery

Gonzalo De Miquel

Mr. Gonzalo De Miquel has been Independent Director at ALK-ABELLO A/S since March 12, 2018. He is Chairman of the Scientific Committee and Member of the Remuneration Committee. He is Chief Medical Officer and EVP of Development at Vectura Ltd. and Board Member of Ventaleon Ltd.

Per Plotnikof